Literature DB >> 24719417

Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.

John Karijolich1, Yang Zhao2, Bret Peterson1, Qiang Zhou2, Britt Glaunsinger3.   

Abstract

UNLABELLED: Robust activation of human immunodeficiency virus type 1 (HIV-1) gene expression occurs upon superinfection with Kaposi's sarcoma-associated herpesvirus (KSHV), a common AIDS-associated pathogen. Though the mechanisms underlying this phenotype remain unknown, several KSHV-encoded factors have been reported to stimulate HIV-1 long terminal repeat (LTR) activity. Here, we systematically evaluated the ability of KSHV tegument proteins to modulate the activation of an integrated HIV-1 LTR and revealed that the most potent individual activator is ORF45. ORF45 directs an increase in RNA polymerase II recruitment to the HIV-1 LTR, leading to enhanced transcriptional output. ORF45 is a robust activator of the p90 ribosomal S6 kinases (RSK), and we found that this activity is necessary but not sufficient to increase transcription from the LTR. Of the three widely expressed RSK isoforms, RSK2 appears to be selectively involved in LTR stimulation by both KSHV ORF45 and HIV-1 Tat. However, constitutively active RSK2 is unable to stimulate the LTR, suggesting that ORF45 may preferentially direct this kinase to a specific set of targets. Collectively, our findings reveal a novel transcriptional activation function for KSHV ORF45 and highlight the importance of RSK2 in shaping the transcriptional environment during infection. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) is a prominent AIDS-associated pathogen. Previous studies have shown that infection of cells containing human immunodeficiency virus type 1 (HIV-1) with KSHV leads to potent stimulation of HIV-1 gene expression by activating the HIV-1 promoter, termed the long terminal repeat (LTR). Here, we compared the abilities of various KSHV proteins to activate gene expression from the HIV-1 LTR and found that KSHV ORF45 is the most potent activator. ORF45 is known to induce cell signaling through ribosomal S6 kinase (RSK) and enhance protein translation. However, we revealed that the activation of a specific isoform of RSK by ORF45 also leads to increased mRNA synthesis from the LTR by the host RNA polymerase. Collectively, our findings provide new insight into the interviral interactions between KSHV and HIV that may ultimately impact disease.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719417      PMCID: PMC4054375          DOI: 10.1128/JVI.00931-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity.

Authors:  Philipp Kaldis
Journal:  J Biol Chem       Date:  2005-01-21       Impact factor: 5.157

2.  Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.

Authors:  Ersheng Kuang; Fayi Wu; Fanxiu Zhu
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

3.  Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  Virology       Date:  2011-02-25       Impact factor: 3.616

4.  Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1.

Authors:  L M Huang; M F Chao; M Y Chen; Y P Chiang; C Y Chuang; C Y Lee
Journal:  J Biol Chem       Date:  2001-01-11       Impact factor: 5.157

5.  BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.

Authors:  Camellia Banerjee; Nancie Archin; Daniel Michaels; Anna C Belkina; Gerald V Denis; James Bradner; Paola Sebastiani; David M Margolis; Monty Montano
Journal:  J Leukoc Biol       Date:  2012-07-16       Impact factor: 4.962

6.  Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.

Authors:  Angelika Chandra; Ilhan Demirhan; Charles Massambu; Pawan Pyakurel; Ephata Kaaya; Malin Enbom; Willy Urassa; Annika Linde; Thomas Heiden; Peter Biberfeld; Hans W Doerr; J Cinatl; Johannes Loewer; Prakash Chandra
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

7.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

8.  Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.

Authors:  S Jacquot; K Merienne; D De Cesare; S Pannetier; J L Mandel; P Sassone-Corsi; A Hanauer
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  13 in total

1.  ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Shumin Du; Denis Avey; Yuqing Li; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Activation and degradation of open reading frame 45 by the replication and transcription activator of Kaposi's sarcoma-associated herpesvirus.

Authors:  Ying Wang; Kai Yu; Xiuzhi Pei; Tianzheng Zhang; Yuying Guo; Charles Wood; Jinzhong Wang
Journal:  J Gen Virol       Date:  2015-03-17       Impact factor: 3.891

3.  A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses.

Authors:  Joseph Gillen; Wenwei Li; Qiming Liang; Denis Avey; Jianjun Wu; Fayi Wu; JinJong Myoung; Fanxiu Zhu
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

4.  Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses.

Authors:  Bishi Fu; Ersheng Kuang; Wenwei Li; Denis Avey; Xiaojuan Li; Zachary Turpin; Ahmed Valdes; Kevin Brulois; Jinjong Myoung; Fanxiu Zhu
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

5.  The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation.

Authors:  Dina Alzhanova; James O Meyo; Angelica Juarez; Dirk P Dittmer
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

6.  Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication.

Authors:  Denis Avey; Sarah Tepper; Wenwei Li; Zachary Turpin; Fanxiu Zhu
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

Review 7.  Co-infections and Pathogenesis of KSHV-Associated Malignancies.

Authors:  Suhani Thakker; Subhash C Verma
Journal:  Front Microbiol       Date:  2016-02-15       Impact factor: 5.640

8.  A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression.

Authors:  Trever T Greene; Maria Tokuyama; Giselle M Knudsen; Michele Kunz; James Lin; Alexander L Greninger; Victor R DeFilippis; Joseph L DeRisi; David H Raulet; Laurent Coscoy
Journal:  Elife       Date:  2016-11-22       Impact factor: 8.140

Review 9.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

10.  Identification of p90 Ribosomal S6 Kinase 2 as a Novel Host Protein in HBx Augmenting HBV Replication by iTRAQ-Based Quantitative Comparative Proteomics.

Authors:  Li-Bo Yan; You-Jia Yu; Qing-Bo Zhang; Xiao-Qiong Tang; Lang Bai; FeiJun Huang; Hong Tang
Journal:  Proteomics Clin Appl       Date:  2018-02-06       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.